Skip to main content

CORRECTION article

Front. Immunol., 19 August 2020
Sec. Cytokines and Soluble Mediators in Immunity
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.01862

Corrigendum: Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis

This article is a correction to:

  1. Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis

    1. Read original article
\nHyun Sik Na&#x;Hyun Sik Na1†Jin-Sil Park&#x;Jin-Sil Park1†Keun-Hyung ChoKeun-Hyung Cho1Ji Ye KwonJi Ye Kwon1JeongWon ChoiJeongWon Choi1Jooyeon JhunJooyeon Jhun1Seok Jung KimSeok Jung Kim2Sung-Hwan Park,Sung-Hwan Park1,3Mi-La Cho,, Mi-La Cho1,4,5*
  • 1The Rheumatism Research Center, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  • 2Department of Orthopedic Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  • 3Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  • 4Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  • 5Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, South Korea

A Corrigendum on
Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis

by Na, H. S., Park, J.-S., Cho, K.-H., Kwon, J. Y., Choi, J., Jhun, J., et al. (2020). Front. Immunol. 11:730. doi: 10.3389/fimmu.2020.00730

In the original article, we neglected to include the funder “Ministry of Health & Welfare, Republic of Korea, HI15C1062” to author M-LC in the Funding statement.

The corrected statement is as follows:

“This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C1062), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C3062), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number NRF-2018R1D1A1B07048554).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: osteoarthritis, inflammation, interleukin-17, IL-1 receptor antagonist knockout, intestinal homeostasis

Citation: Na HS, Park J-S, Cho K-H, Kwon JY, Choi J, Jhun J, Kim SJ, Park S-H and Cho M-L (2020) Corrigendum: Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis. Front. Immunol. 11:1862. doi: 10.3389/fimmu.2020.01862

Received: 30 June 2020; Accepted: 10 July 2020;
Published: 19 August 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Na, Park, Cho, Kwon, Choi, Jhun, Kim, Park and Cho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mi-La Cho, aWFtbWlsYSYjeDAwMDQwO2NhdGhvbGljLmFjLmty

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.